Left atrial volume index

LAVI · LA-focused (not LV-focused) apical 4- and 2-chamber views, end-systole, biplane method of discs

Normal range & thresholds

Pathophysiology

Raised by

• Chronic elevation of LA pressure of any cause — HFpEF and HFrEF, hypertensive heart disease, HCM, amyloid and other restrictive disease
• Mitral regurgitation and mitral stenosis
• Atrial fibrillation and atrial flutter (an independent cause — interpret LAVI cautiously as a filling-pressure marker in AF)
• Bradycardia and complete heart block; endurance athletes (up to ≈40 mL/m²)
• Chronic anaemia, renal failure with volume overload, arteriovenous fistula
• Left-to-right shunt; constrictive pericarditis (mild)

Lowered by

• Hypovolaemia and over-diuresis — a genuinely dilated atrium can index below 34 mL/m² when dry
• Tamponade; extrinsic compression
• Small body surface area with a technically foreshortened atrium (usually artefact rather than truth)

Technique & pitfalls

• Use LA-focused apical views. Optimising the image for the left ventricle almost always foreshortens the atrium and under-measures it — the single commonest error with this parameter.^[1]
• Measure at end-systole (maximum LA volume), on the frame before mitral valve opening.
• Exclude the left atrial appendage, the pulmonary veins, and the area under the mitral annular plane.
• Biplane method of discs is preferred; the area–length method is acceptable but gives different numbers — keep to one method on serial studies.
• Index to BSA and report the index, not the raw volume.
• If the atrium is very asymmetric (post-ablation, after mitral surgery), 3D volumes are more accurate.

Pseudo-change & artefact

• Foreshortening — systematically underestimates, and it is the reason LAVI is under-reported as normal in real laboratories.
• Including the appendage or the pulmonary vein ostia — overestimates.
• Tracing at the wrong phase of the cardiac cycle.
• Volume status on the day; heart rate and rhythm.
• Method drift between 2D biplane, area–length, and 3D: differences of 10–25%.
• In atrial fibrillation, LAVI reflects the arrhythmia as much as the filling pressure — the 2025 guideline explicitly demotes structural markers in AF.^[2]

Treatment thresholds

• Asymptomatic severe primary mitral regurgitation: LAVI ≥60 mL/m² in sinus rhythm with preserved LVEF is an accepted trigger for mitral valve surgery (class IIa) — an atrial, not ventricular, indication.^[6,7]
• HFpEF diagnosis: LAVI >34 mL/m² in sinus rhythm is a major morphological criterion in HFA-PEFF and part of the 2025 ASE HFpEF section; it contributes to H₂FPEF.^[2,101,102]
• Filling pressures: LAVI >34 mL/m² is a step-2 supplemental marker of elevated LAP when the three primary variables (e′, E/e′, TR velocity) are discordant.^[2]
• Aortic stenosis staging: left atrial enlargement with raised filling pressure defines stage 2 cardiac damage and independently predicts mortality after AVR — increasingly used to justify earlier intervention.^[58,103]
• Stroke risk and rhythm: a dilated atrium supports prolonged rhythm monitoring and informs the rhythm-control decision.^[40]

Next step

• Next: complete the diastolic assessment (e′, E/e′, TR velocity, LA reservoir strain) and interrogate the mitral valve.
• Then: if LAVI is high but the resting filling pressures look normal and the patient is dyspnoeic, do a diastolic stress echo — exercise E/e′ ≥15 with TR velocity >2.8–3.4 m/s confirms HFpEF.^[105,106]
• Then: ambulatory monitoring for AF; natriuretic peptides; CMR if infiltrative disease is possible.
• Then: in severe MR with LAVI ≥60 mL/m², refer to the Heart Team even in the absence of symptoms.

Drugs

• Falls with effective decongestion (loop diuretics), RAAS blockade, ARNI and SGLT2 inhibitors — PROVE-HF documented significant LAVI reduction alongside ventricular reverse remodelling.^[68,69]
• Falls with restoration and maintenance of sinus rhythm (antiarrhythmics, ablation).
• Rises with anything that sustains elevated filling pressures, and with chronic alcohol.
• Non-pharmacological but powerfully effective: weight loss, exercise training, CPAP for sleep apnoea.

Reversibility